Clinical trial
307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in…
NCT00255502 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00255502 |
|---|---|
| Title | 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects |
| Official title | A Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® (Metoprolol Succinate) Extended-release Tablets (Metoprolol CR/XL) in Hypertensive Pediatric Subjects: A Multicenter, Open-Label Extension of Protocol 307A |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | metoprolol succinate |
| Enrollment | 100 |
| Start date | Jul 1, 2002 |
| First posted | Nov 21, 2005 |
| Last update posted | Jan 18, 2020 |
| Countries | Dominican Republic, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: